Joël Guigay is Professor of Medicine, Past Director of Cancer Center Antoine-Lacassagne in Nice, France and Past President of the Head & Neck-Unicancer group. Prior to this, he was Head Physician in the Department of Head & Neck and Thoracic Medical Oncology at Gustave Roussy in Villejuif, France. Professor Guigay received his Medical Degree from Lyon University of Medicine in 1984 and subsequently undertook extensive postgraduate training in Pneumology, Cancerology, Oncogenesis, and Thoracic Endoscopy. In 2001, he was appointed Professor of Medicine at the Hôpital d’Instruction des Armées Val-de-Grâce in Paris, France.

He currently serves as Head of partnerships and clinical development - Early assets for the Groupe Oncologie Radiothérapie Tête et Cou (GORTEC), Tours, France and as deputy director of the Hospital University Federative OncoAge in Nice, France. In addition, he is an active member of many national and international societies, including the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO) as a Faculty member for Head and Neck cancers and as a member of the OncologyPRO Working Group.

His main fields of interest are head and neck and lung oncology with a focus on rare tumours, salivary gland tumours, nasopharyngeal cancers and neuroendocrine tumours. His aeras of research include clinical studies with new drugs and translational research with a focus on immunotherapy. Professor Guigay coordinates several clinical trials including phase I to large randomized trials in recurrent or metastatic HNSCC such as TPExtreme trial. He is currently also leading a large research programme for elderly head and neck cancer patients (ELAN programme).